2nd Jun 2017 7:00 am |
RNS |
OXB to Present at Jefferies Healthcare Conference |
1st Jun 2017 12:22 pm |
RNS |
Total Voting Rights |
24th May 2017 1:55 pm |
RNS |
Director/PDMR Shareholding |
23rd May 2017 2:03 pm |
RNS |
Result of AGM |
4th May 2017 8:46 am |
RNS |
Total Voting Rights |
28th Apr 2017 7:00 am |
RNS |
Annual Report and Accounts & AGM Notification |
24th Apr 2017 10:17 am |
RNS |
Director/PDMR Shareholding |
4th Apr 2017 7:00 am |
RNS |
Holding(s) in Company |
3rd Apr 2017 9:11 am |
RNS |
Total Voting Rights |
31st Mar 2017 7:15 am |
RNS |
Hardman: Delivering commercial gene-therapy vector |
30th Mar 2017 7:02 am |
RNS |
BLA filing for CTL019 |
27th Mar 2017 10:44 am |
RNS |
Publication in the Journal Nature Communications |
23rd Mar 2017 1:47 pm |
RNS |
Director Dealings |
22nd Mar 2017 7:00 am |
RNS |
Holding(s) in Company |
16th Mar 2017 7:00 am |
RNS |
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2016 |
10th Mar 2017 7:00 am |
RNS |
Notice of Preliminary Results |
1st Mar 2017 10:24 am |
RNS |
Total Voting Rights |
28th Feb 2017 7:00 am |
RNS |
Appointment of New Chief Financial Officer |
24th Feb 2017 9:36 am |
RNS |
Director Dealings |
24th Feb 2017 7:00 am |
RNS |
Results of TroVax® in Advanced Colorectal Cancer |
1st Feb 2017 10:09 am |
RNS |
Total Voting Rights |
25th Jan 2017 9:02 am |
RNS |
Director/PDMR Shareholding |
24th Jan 2017 4:34 pm |
RNS |
Director Dealings / Market Share Purchase |
24th Jan 2017 9:31 am |
RNS |
Director/PDMR Shareholding |
23rd Jan 2017 9:57 am |
RNS |
Director/PDMR Shareholding |
3rd Jan 2017 9:30 am |
RNS |
Block Listing Return |
3rd Jan 2017 9:28 am |
RNS |
Total Voting Rights |
20th Dec 2016 8:57 am |
RNS |
Director/PDMR Shareholding |
12th Dec 2016 10:52 am |
RNS |
Block listing application |
6th Dec 2016 9:15 am |
RNS |
Director/PDMR Shareholding |
5th Dec 2016 10:25 am |
RNS |
Findings Reported by Novartis on CTL-019 at ASH |
5th Dec 2016 9:43 am |
RNS |
Director/PDMR Shareholding |
1st Dec 2016 9:27 am |
RNS |
Total Voting Rights |
29th Nov 2016 7:00 am |
RNS |
Strategic Alliance with Orchard Therapeutics |
28th Nov 2016 10:06 am |
RNS |
Director/PDMR Shareholding |
8th Nov 2016 6:28 pm |
RNS |
Grant of options (Replacement) |
8th Nov 2016 6:13 pm |
RNS |
Grant of options |
1st Nov 2016 10:21 am |
RNS |
Total Voting Rights |
25th Oct 2016 4:40 pm |
RNS |
Director/PDMR Shareholding |
10th Oct 2016 7:21 am |
RNS |
Publication of RetinoStat® (OXB-201) Phase I study |